LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
12.65
-0.12 (-0.90%)
Aug 14, 2025, 11:30 AM - Market open
LENSAR Market Cap
LENSAR has a market cap or net worth of $150.92 million as of August 14, 2025. Its market cap has increased by 143.41% in one year.
Market Cap
150.92M
Enterprise Value
134.31M
1-Year Change
143.41%
Ranking
Category
Stock Price
$12.65
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $150.92M, an increase of 93.46%. That is a compound annual growth rate of 14.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 154.20M | 48.50% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | 77.13M | -1.12% |
| Oct 2, 2020 | 78.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 587.50B |
| Johnson & Johnson | 418.11B |
| AbbVie | 354.21B |
| UnitedHealth Group | 242.91B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.25B |
| Novo Nordisk | 223.00B |